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                                                 ABSTRACT 
Bacteria produce a range of proteolytic enzymes (for which a number human 
equivalent or structurally similar examples exist) and the primary focus of this 
study was to analyse the published literature to find proteolytic enzymes, 
specifically endoproteses and to examine the similarity in the substrates that 
they act on so as to predict a suitable structural motif which can be used as 
the basis for preparation of useful prodrug carriers against diseases caused 
by specific bacteria like Salmonella. Also, the similarities between the 
bacterial proteases and the action of human matrix metalloproteinases 
(MMPs), together with the MMP-like activity of bacterial endoproteases to 
activate human MMPs, were also analysed. This information was used to try 
to identify substrates on which the MMPs and bacterial proteases act, to aid 
the design of oligopeptide prodrug carriers to treat cancer and its metastatic 
spread. MMPs are greatly involved in cancer growth and progression, a few 
MMPs and certain proteases share a similar type of activity in degrading the 
extra cellular matrix (ECM) and substrates including gelatin. Our primary 
targets of study were to identify the proteases and MMPs that facilitate the 
migration of bacteria and growth of tumour cells respectively. The study was 
thus a two-way approach to study the substrate specificity of both bacterial 
proteases and MMPs, thereby to help in characterisation of their substrates. a 
Various bioinformatics’ tools were used in the characterisation of the 
proteases and substrates as well as in the identification of possible binding 
sites and conserved regions in a range of candidate proteins. Central to this 
project was the salmonella derived PgtE surface protease that has been 
shown recently to act upon the pro-forms of human MMP-9. 
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 1. INTRODUCTION  
 
1.1 Cancer, ECM and Proteases 
Cancer has been a well-known disease since antiquity, though its relevance 
increased once the average life expectancy of man increased considerably 
due to science and technological advances, since most cancers are 
associated with increasing age. In a report by The American Cancer Society 
in 2007, cancer is thought to have caused about 13% of all human death in 
that year, which is equal to about 7.6 million deaths annually (Fox and Walsh, 
2008).  This is a compelling reason for the widespread effort throughout the 
world, which is being carried out to fight this menace, including preventive 
measures, academic research, and drug development. Generally cancer 
involves uncontrolled growth of cells, invasiveness and may involve the 
spread of cancerous cells to other parts of the body via routes such as blood; 
this process is called metastasis. About 150 years ago, a German 
microscopist suggested that solid tumors were made of a mass of cells, which 
was likely the starting point to study the differences between normal and 
tumor cells, which would eventually lead to develop treatment against cancer 
(Franks and Teich, 1997).  
 
The role of non-malignant cells that are present in the close proximity of tumor 
cells in the progression of tumor was not well known until recently (Hanahan 
and Weinberg, 2000). The tumor cell’s microenvironment consisting of various 
cells like fibroblasts, inflammatory cells, endothelial cells and myoepethial 
cells etc can affect the behaviour of tumor cells significantly. Apart from these 
cells the extracellular matrix (ECM) and its proteins create a non-cellular 
compartment around the tumor (DeClerck et al., 2004). Different proteases 
produced by both non-neoplastic and neoplastic cells, as well as those 
present on the surface of the cells modify and remodel this non- cellular 
compartment, also new signals are produced and important changes in the 
cell to cell and cell to ECM interactions take place due to the action of these 
proteases (Liotta and Kohn, 2001). Important cellular characteristics such as 
survival, motility, differentiation, and proliferation are affected ultimately by 
these signals via altering the gene expression in the cell (Werb, 1997). 
 
EMT or Epithelial to Mesenchymal Transformation is the process in 
development by which the basolateral polarity and strong intracellular 
adhesion features of epithelial cells are lost, and by which in turn they gain 
ability to move through the ECM (Savagner, 2001). As cells lose contact with 
each other the interactions between cells and the ECM are generated, which 
leads to change in function of several adhesion molecules present on the cell 
surface, which might now become the source of various signals promoting 
motility, growth, ECM degradation and metastasis.  
 
The role of proteases in cancer has been substantially studied, where the 
main focus of various research groups has been to assess the critical role of 
proteases in the degradation of the ECM, which facilitates the penetration of 
tumor cells into blood vessels and surrounding connective tissue (Koblinski et 
al., 2000). In particular the effect of a certain class of proteases called MMPs 
or matrix metalloproteinases has been widely studied and their role in ECM 
degradation analyzed. Although MMPs are essential in the breakdown of 
ECM in normal physiological processes such as tissue remodelling, 
reproduction and embryonic development, their role in tumour progression is 
more widely studied (Nagase and Woessener, 1999). For example, MMP-7 or 
matrilysin is widely expressed by breast tumour cells and its been observed 
that it causes visible breaks in the basement membrane by cleaving matrix 
components in the cellular environment (Noe et al., 2001).  However MMP- 7 
is not only involved in the breakdown of ECM in cancer but also has other 
functions; it also cleaves E- cadherin, which is a cell adhesion molecule, 
thereby causing epithelial cell disruption, increased invasiveness of the cell 
and high saturation density (Fingleton et al., 2001). Likewise all the MMPs 
have different functions relating to tumour development along with the 
degradation of the ECM (Fridman, 2006).  
 
Proteases are normally expressed as inactive forms in the extracellular 
environment and are activated by various mechanisms including peptide 
cleavage. However many of the antibodies are unable to distinguish between 
the active and inactive forms of proteases, so immunohistometry studies 
showing over expression of proteases doesn’t always means there is 
increased proteolytic activity (Coussens et al., 2002).  These proteases have 
been traditionally considered as targets for anti- cancer treatments because of 
their obvious involvement in tumour growth and progression. Most studies on 
targeting proteases for cancer treatments involve the following standpoints, 
finding the proteases that are involved in malignant progression, validation of 
the found proteases as possible targets for therapy, development of assays 
that help to analyze the proteolytic activities and cellular interactions inside a 
solid tumor and also to develop non invasive imaging techniques to study the 
actions of these proteases and thereby developing suitable anti-protease 
therapies (Mahmood and Weissleder, 2003). There are many natural protease 
inhibitors in nature, which effectively inhibit the function of proteases; alpha-1 
antitrypsin is a well-known protease inhibitor whose deficiency is associated 
with emphysema and liver disease (Crystal, 1990). However there has also 
been a problem with synthetic inhibitors of proteases for cancer treatment that 
have not been deemed efficacious in clinical trials; for example, preclinical 
studies of MMPIs or the MMP inhibitors have shown that they are efficacious 
in prevention techniques or during early stages of tumor growth but not in later 
stages of cancer. MMP inhibitors have been used like cytotoxic drugs, but 
actually they are cytostatic in nature, so they won’t cause tumour shrinkage at 
later stages of cancer, though they maybe useful as preventive measures 
(Egebald and Werb, 2002).  Also an efficient method for systemic delivery is 
not available, which poses a further problem for utilising this technique 
(Brown, 1997). Further the use of protease inhibitors have also known to have 
some side effects, which have been observed in treatment against cancer, 
bacterial diseases and AIDS (Tsiodras et al., 2009). 
 
1.2 Matrix Metallopeptidases 
The Matrix Metallopeptidases or MMPs as they are commonly known are a 
class of endopeptidases containing catalytic Zinc group and their primary 
function involves the degradation of the ECM and its components. A common 
property of the MMPs include that they are generally in the form of inactive 
zymogens which have to be activated by proteolytic cleavage (Harper et al., 
1971). Normally they are expressed only during processes such as wound 
healing, reproductive functions like embryonic development, placenta 
development etc. However, abnormal functions of MMPs have been 
connected to various diseases such as rheumatoid arthritis, gastroenteritis, 
periodontitis and cancer (Woessener et al., 1991). 
 
The structure of MMPs normally is made up of a catalytic domain, which is 
about 180 amino acids long, a propeptide region of about 80 amino acids, a 
linker or hinge region of variable length and a hemopexin domain equal to 
about 200 amino acids (Jones et al., 2003). However MMP-7, MMP-23 and 
MMP-26 are exceptions to the general structural formula since they don’t 
have the hemopexin domain and hinge region. MMP-23 also possesses a 
unique region rich in cysteine and an immunoglobulin domain, further, MMP-2 
and MMP-9 have three repeats of a fibronectin motif in the metalloproteinase 
domain (Nagase et al., 2006).. There are some common structural signatures 
are there as well among MMPs, in the catalytic domain there is a zinc binding 
motif HEXXHXXGXXH and also there is the motif PRCGXPD known as 
cysteine switch in the propeptide region. The cysteine and zinc coordination is 
required to keep the MMPs in an inactive state; a Met-turn is also formed with 
a conserved methionine present in the catalytic domain, which provides the 
support for the catalytic zinc in the form of a structural base (Bode et al., 
1993). 
 
1.2.1 MMPs and Bacterial Diseases 
MMPs have proteolytic affinities that are found to be overlapping and they can 
cause degradation of the extracellular matrix. MMPs are also divided into 
elastases, collagenases, stromelysins and gelatinases based on their 
substrate specificity. These substrates also contain cytokines, proteinases, 
chemokines and inhibitors of the proteinases along with the ECM components 
(McCawley and Matrisian, 2001). The Cysteine and Zinc binding maintains 
the inactive form of MMP and an intermediate activation could be caused by 
even other MMPs or by molecules such as Trypsin and Plasmin. But for 
complete activation another cleavage has to happen, which might be 
autocatalytic (Johansson et al., 2000). Many MMPs’ expression is brought 
about by various outside signals such as contact with surface components of 
microbes or the ECM (Opdenakker et al., 2001). It has been observed that 
host cell like monocytes produce MMPs during invasion by viruses and 
bacteria (Elkington et al, 2005). Previous studies have shown that some 
bacteria activate host proMMPs through their proteolytic enzymes, which 
includes bacteria such as Vibrio cholerae, Treponema denticola, 
Pseudomonas aeruginosa, pneumoniae bacteria (Okamoto et al, 1997) and 
Porpyromonas gingivalis (Pattamapun et al, 2003). The LPS from enteric 
bacteria such as Salmonella also induces macrophages to secrete proMMP-9 
(Xie et al., 1994). Also gelatinase and collagenase production has been 
observed in some bacteria (Watanabe, 2004). It has also been observed that 
mice deficient in MMP- 3 have comparatively high resistance against systemic 
Salmonella infection than normal mice (Handley and Miller, 2007) and MMP-9 
deficient mice have high resistance towards enterocolitis caused by 
Salmonella (Castaneda et al, 2005). All these results have shown that there is 
a probable case of MMPs taking part in Salmonella infections.  
 
1.2.2 MMPs and Cancer 
Angiogenesis is an important part of cancer progression, it involves various 
steps including degradation of the basement membrane on an existing blood 
vessel, migration and proliferation of endothelial cells into the new space, 
maturation, differentiation, and adherence of the endothelial cells to each 
other, and lumen formation. The initiation of angiogenesis may be brought 
about by various factors from cells such as macrophages, mast cells, 
inflammatory cells or tumor cells (Brooks, 1996). They bind to the matching 
cell surface receptors and among other things such as activation, proliferation, 
migration and invasion functions of the cell; they also induce the secretion of 
MMPs (Eliceiri and Cheresh, 2001). MMPs are involved in angiogenesis, in 
processes such as degradation of the ECM, its components and the 
basement membrane, so that the endothelial cells can migrate to new tissue. 
This process also causes integrin intracellular signalling, for example, it has 
been observed that MMP-2 initiates integrin signalling and may help in 
endothelial cell proliferation and survival. MMPs also generate other 
endogenous angiogenesis factors, such as angiostatin, endostatin and in the 
case of MMP-2 even the generation of a hemopexin by autoactivation 
(Stevenson, 1999). This shows that MMPs have both pro and anti angiogenic 
activities, however generally MMPs help in angiogenesis and MMP inhibitors 
suppress angiogenesis in experimental models (Naglich et al., 2001). During 
cancer progression in humans, especially in advanced stages, during invasive 
progression, metastasis and poor prognosis, MMP expression has been found 
to be increased (Coussens et al., 2002)). Early MMP expression, which might 
be caused by neighbouring cells or the tumor cells themselves, might help in 
ECM degradation and setting up of the microenvironment for cancer growth 
and primary establishment. They remove adhesion sites, expose new binding 
sites, break cell-matrix or cell-cell receptors and also release 
chemoatttractants from the extracellular matrix thereby aiding in the migration 
of tumor cells (McCawley and Matrisian, 2001). Along with intravasation 
MMPs are also required for extravasation of tumor cells from the blood cells, 
although this process does not seem to have a rate limiting effect in 
metastasis (Chambers and Matrisian, 1997). This shows that in the 
carcinogenic process MMPs are involved in multiple different stages. There is 
also a switch that accompanies the tumor growth at a certain point whereby 
the expression of pro angiogenic factors start outweighing the expression of 
angiogenic inhibitors; different model systems have implicated both MMP-2 
and MMP-9 in causing this angiogenic switch (Egeblad and Werb, 2002). The 
idea for developing MMP inhibitors for cancer treatment has been around for 
a considerable time, though good results have been obtained from animal 
studies but converting these results into clinical trials in humans has not been 
as promising. The reasons for this can be associated with the poor 
bioavailability MMP inhibitors of the first generation and second-generation 
MMP inhibitors causing unwanted side effects (Overall and Otin, 2002). From 
the known roles of MMPs in the entire carcinogenesis process it could be 
hypothesized that MMP inhibitors might have betted effect if administered to 
patients at early stages of cancer development. Though study on inhibiting 
MMPs to treat cancer has been widely studied, there has been comparatively 
a meagre amount of study on utilizing these proteases for drug delivery and 
chemotherapy purposes. 
 
1.2.3 MMPs in Drug Delivery 
The primary focus of drug delivery for many has been to find a ‘’magic bullet’’ 
(Ehrlich and Bolduan, 1906). If we are able to devise delivery systems that 
would allow drugs to target the necessary site leaving out other parts of the 
body, that would help to destroy that particular disease. Unfortunately, this 
has not been the case most diseased tissues remain to normal except that 
they show increased or decreased level of the biological processes compared 
to normal tissues. This gives rise to the idea to find the biological processes or 
targets in which most difference is seen between normal and diseased 
tissues, so as to differentiate them, one such target is the MMP. Tumours are 
surrounded by a unique microenvironment, an over production of proteases 
(Egeblad and Werb, 2002) and slightly increased acidic pH could be observed 
generally (Gerweck and Seetharaman, 1996). And MMPs are overproduced 
as well, since they are essential in the carcinogenic process. Previously, to 
locate or identify tumours as well as to turn on or activate imaging agents, this 
over expression of MMPs has been utilized (Weissleder et al., 1999; Mok et 
al., 2009). The same has been done with imaging based therapy for other 
diseases such as arthiritis (Lee et al., 2008) and monitoring response for 
treatments (Wunder et al., 2004). On of the very recent methods of drug 
delivery has been the use of custom created nanocarriers that transfer a drug 
payload to the target site. And the optimum way to do that is to keep them 
inactive until they reach the target site for efficient target delivery. The 
activation of these nanocarriers could be programmed, so that, they get 
activated by factors in the tumor microenvironment, to increase successful 
targeting.  The acidic pH as well as the over expressed enzymes could be 
utilized for this purpose. By using a peptide linker to connect methotrexate 
and dextran a drug polymer conjugate was formed, which was observed to be 
cleaved by MMP-9 and MMP-2 (Chau et al., 2004). But in this study it was 
observed that there was not much difference in the uptake of drugs from MMP 
sensitive and MMP insensitive drug polymer conjugate. Though the reason for 
this might because the cleavage of the linker happened there was endocytic 
uptake of the conjugate itself (Chau et al., 2006). Also the efficacy of MMP 
sensitive and insensitive conjugates was much higher compared to free drug 
in various MMP over expressing tumor models (Chau et al., 2006). Another 
study reports the idea to use a MMP sensitive peptide to link 1,2-dioleoyl-sn- 
glycero-3-phosphoethanolamine and polyethylene glycol (PEG), this study 
showed in MMP over expressing tumors MMP sensitive conjugates induced 
three times higher gene transfection than done by MMP insensitive 
conjugates (Hatekeyama et al., 2007).  The structure of the various MMPs 
differ significantly which might enhance their substrate specifity, the catalytic 
domains contain various residues and is responsible for catalysis and binding, 
though other discrete binding domains exist as well in other regions in the 
MMP, which further increases specificity for substrates (Overall, 2002). To 
find the substrate specifity of MMPs various methods such as genetic 
knockout, proteomics based methods and affinity methods could be used 
(Tam et al., 2004). If we consider the cleavage site of a substrate for MMP as 
…P3 - P2 - P1 ~ P1’ - P2’ -P3’… where P could represent any amino acid and 
cleavage will happen between P1 and P1’. MMPs generally prefer small 
residues such as Serine at P1, hydrophobic residues at P1’ and P2, basic or 
hydrophobic residues at P2’ and Proline at P3. Though most of these 
preferences are common for most MMPs, there has also been some 
differences, for example, MMP-1, MMP-2 and MMP-9 prefer small residues at 
P3’, whereas MMP-3, MMP-7 and MMP-14 prefer methionine (Vartak and 
Gemeinhart (2007), This way by analyzing substrate specificities of the MMPs 
its possible to design substrates that will be specifically cleaved by selected 
MMPs and could be used for targeted drug delivery (Turk et al., 2001). 
 
1.3 Bacterial Endopeptidases 
Endopeptidases can be classified as a class of peptide hydrolases that cleave 
peptides or proteins internally, the peptide bonds of non-terminal amino acids 
are broken in contrast to other peptidases that break bonds from the terminal 
pieces (Cassarini et al., 1999).  Endopeptidases cannot cleave peptides to 
form monomers and they are normally identified based on the specifity in 
which they cleave. For example, Trypsin is a very specific endopeptidase, 
which always cleaves after Lysine or Arginine, unless when either is followed 
by Proline (Leiros et al., 2004). Endopeptidases are further classified in to 
serine proteases, threonine proteases, cysteine proteases, aspartic acid 
proteases and metalloendopeptidases based on the amino acid present in 
their active site. In the case of metalloendopeptidases the active site includes 
a metal such as zinc and at times cobalt and manganese (Hashimoto, 1983). 
The aspartic acid proteases and metalloproteases are different from the other 
proteases in that their nucleophile in the catalytic site consists of a water 
molecule compared to the amino acid of the other proteases (Barrett et al., 
1998). 
 
Bacterial produce a variety of proteases and their role in virulence factors of 
the various bacteria are very evident. Its well known that bacterial proteases 
have the ability to destroy important host defence proteins, such as those 
present in the complement system which is the main part of a host’s innate 
immunity (Popadiak et al., 2007), as well as degrade the functional and 
structural proteins present in the host organism (Maeda, 1996). More specific 
roles for bacterial proteases have recently been observed in the interaction 
between the host organism and the invading bacteria that includes, blocking 
of cascade activation pathways and cytokine network, cleavage of receptors 
found on the surface of the cell, and inactivation of the protease inhibitors 
present in the host organism (Rice et al., 1999). Also it should be noted that 
the ability of bacteria to use the proteases it produces to pass the 
proteinaceous barriers present inside a host organism is a major part of 
bacterial virulence.  A more interesting fact is that bacteria use proteases to 
acquire or activate the function of host proteases to help in its growth or 
progression of disease (Lantz, 1997). Bacterial protease can be targeted for 
producing new type of antibiotics, since the inhibition of their functions would 
result in the death of the invading bacteria (Travis and Potempa, 2000). 
Though targeting proteases for creating inhibitors has proven to be a useful 
idea for therapeutic intervention against bacteria, utilizing these proteases or 
taking advantage of their functions to help in drug delivery techniques have 
not been widely tried. 
 
1.3.1 Salmonella and PgtE 
Salmonella spp. based diseases cause more than 3 million deaths annually 
and it is one of the most important food borne infections all over the world 
(Pang et al., 1995). Salmonella consists of two species with very different 
characteristics regarding effects on human beings. S. enterica is highly 
pathogenic to humans as well as most warm-blooded animals, unlike S. 
bongori, which rarely causes human diseases (Giammanco et al., 2002). 
Salmonella and Escherichia coli are genetically related and they share 
approximately 80% similarity in their genomic sequence (McClelland et al, 
2001). Also has been hypothesized that Salmonella and E. coli may have 
diverged from an ancestor some 120 million years before, after which they 
developed various phenotypic changes that differentiate these from each 
other (Ochman and Wilson, 1987). Salmonella enterica serovars Typhi 
causes the dreaded typhoid, which alone causes over 200000 deaths a year.  
Salmonella enters the body through the ingestion of contaminated food or 
water and it goes through a series of invasion processes including crossing 
the intestinal epithelium and infecting dendritic cells and submucosal 
macropages. Macrophages act as important phagocytes and effectors of the 
adaptive and innate immune responses. S. Typhimurium can survive within 
macrophages intracellularly, where it undergoes the process of replication 
within certain specialised vacuoles (Dalfors et al., 1997). During the infection 
process, it causes the death of the host cells and thus spreads to new cells, 
evidence also suggests that Salmonella disseminates extracellularly, for 
which it should have proteolytic activity (Knodler and Finlay, 2001).  
 
Salmonella enterica possesses an outer membrane protein called PgtE; it is a 
member of the omptin family of proteases (Ramu et al., 2008). We know 
about the functions of certain omptins such as Pla, an outer membrane 
protein of Yersinia pestis, which plays an important role in the invasive 
character of plague (Kukkonen and Korhonen, 2004). Furthermore Pla has 
nearly 75% sequence similarity with PgtE in predicted amino acid sequences 
according to previous studies (Sodeinde and Goguen, 1989).  OmpT of E. coli 
is another omptin that has been widely studied and whose structure was 
obtained through crystallography techniques; it also shares a considerable 
sequence similarity with PgtE (Vandeputte- Rutten et al, 2001). Regarding the 
proteolytic activity of omptins they are observed to cut after the basic residues 
of the polypeptides from the case of OmpT (Dekker et al, 2001). 
 
PgtE degrades alpha-helical CAMPs, which shows that it might play a role in 
resistance towards innate immunity of Salmonella (Guina et al., 2000). Also 
PgtE was identified in degrading viral epitopes, which were fused within a 
Typhimurium strain, in its fimbriae and subsequent increase in antibody 
response was observed by removing PgtE (Chen and Schifferli, 2003). Such 
results show the different types of substrates that PgtE is capable of cleaving. 
PgtE has been found to convert plasminogen to plasmin and also is involved 
in the inactivation of plasmin inhibitors (Lähteenmäki et al., 2005). This 
function is similar to that of Pla, which also inactivates plasmin inhibitors and 
is more proficient in the conversion of plasminogen (Kukkonen et al., 2001). 
Recent studies have shown the interesting property of PgtE to be involved in 
gelatin degradation and proMMP-9 activation. The same study tried to 
analyze whether Pla of Y.pestis and OmpT of E.coli had a similar effect, but 
showed that Pla degraded gelatin poorly and there was no proMMP-9 
activation. Similarly OmpT was also poor in gelatin degradation and proMMP-
9 activation. These results suggest that Salmonella might have separate 
substrate specificity to gelatin and proMMP-9 (Ramu et al., 2007).  
 
By analysing the unique substrates on which PgtE acts on, as well as the 
study of differences in the sequences of PgtE and omptins like Pla and OmpT, 
might be possible to predict a general structural motif for a substrate on which 
PgtE might act. Further homology modelling of PgtE using the structural data 
of OmpT might also prove valuable to study the important active sites, loops, 
which are involved in substrate specificity. Converting OmpT into a Pla-like 
enzyme has been done by substituting critical amino acids that are exposed 
on the surface of the bacteria, this shows that the loop structures on the 
surface play an important role in the specificity of proteolytic properties in 
omptins (Kukkonen et al, 2001). 
 
1.3.2 Photorhabdus and PrtA 
Photorhabdus is the only genus of terrestrial bioluminescent bacteria that has 
been identified and is divided into three known species, P. luminescens, P. 
temperata and P. asymbiotica (Le Saux et al., 1999). Photorhabdus produces 
a certain type of proteases of the class serralysins, which are thought to have 
pathogenecity functions and help in the infection process of the bacteria 
though there is no clear knowledge of serralysin substrates (Marokhazi et al., 
2006). Serralysins are extracellular metalloendopeptidases that show 
complete conservation of Zn+2 binding domain, Met-turn and Ca+2 binding 
repeats (Baumann 1998). PrtA is one such serralysin, which is secreted by 
the bacteria Photorhabdus luminescens, which is found to be extremely 
pathogenic in insects. PrtA is produced during the start of the infection, which 
might because of its role in pathogenecity (Bowen et al., 2000).  Also it is to 
be noted that PrtA is not involved in the bioconversion of host tissues, which 
would rule out its specificity (Daborn et al., 2001), neither does it have 
identifiable direct toxicity unlike several other mettaloproteases (Bowen et al., 
2003).   
 
To study the proteolytic system of PrtA and understand its function in the 
infection of Photorhabdus, the knowledge of its substrate is required. To study 
the cleavage site specificity of PrtA, the sequence was analyzed with some 
biological peptides such as insulin A, insulin B and beta-lipotropin. A 
preference for hydrophobic amino acids at positions P2, P1’ and P2’ was 
observed on cleavage site analysis of the substrate. From the results, it was 
also concluded that the cleavage sequences PrtA are rich in Ala, Leu and Val 
(Markokhazi et al., 2007). A simple probability analysis of amino acid 
frequencies indicated a slightly higher frequency of Leu and Val at position 
P2’, which is in accordance with the presence of a conserved Leu (Leu3, a 
position equivalent to P2’) of the known bacterial inhibitors of serralysin-like 
proteases (Bae et al., 1998). Searching for target proteins using hemolymph 
of M. sexta in the proteolytic system of PrtA has given some results that would 
be useful, totally 16 PAT proteins were found, which were cleaved readily and 
selectively by PrtA. Of the sixteen, 6 were known proteins that have some 
immune related activity. From this it could be supposed that PrtA participates 
in immunosuppressive mechanisms of Photorhabdus, though there is little 
information about the other 10 PAT proteins (Felfoldi et al., 2009). 
 
1.2.3 P. gingivalis and the Gingipains. 
The bacteria Porpyromonas gingivalis is considered to be the important 
etiological agent for the infection and development of chronic periodontitis, 
which is a severe inflammatory disease, which affects the tissues around the 
teeth in adults (Fox, 1992). The pathogenecity of the bacteria is associated 
with various factors such as, the hemagglutinins, fimbriae, LPS and some 
cysteine proteinases called Gingipains and their adhesive factors (Simpson et 
al., 2000). In these factors involved in P. gingivalis pathogenecity, the 
Gingipains, that is, Arginine specific cysteine proteinases (RgpA and RgpB) 
and Lysine specific proteinases (Kgp) are considered to be really important 
since they degrade a number of host proteins and disrupt the hosts defensive 
mechanism (Travis et al., 1997). Of the several functions the Gingipains 
possess, they are able to induce the clotting of blood by causing cascade of 
coagulation at different levels (Imamura et al., 2001), and the thrombin that is 
produced during the clotting process is known to be a proinflammatory 
mediator (DeMichelle et al., 1990). These two functions are responsible for 
the inflammotary effects associated with periodontis.  Further Gingipains can 
degrade fibrinogen (Imamura et al., 1995) and induce the production of 
collagenase through gingival fibroblast resulting in activation of proMMPs 
(DeCarlo et al., 1997). Both Rgp and Kgp have been observed to degrade 
type I collagen directly in mutant studies (Tokuda et al., 1998) and Rgp can 
induce fibroblasts to produce MMP-1 and Kgp can induce the production of 
MMP- 8 (Fitzpatrick et al., 2009).  
 
 
AIM 
The primary aim of this study is to research published literature on the 
proteases of interest, analyse their substrate specificities and recommend the 
requirements for a possible structural motif in the development of carriers for 
prodrugs. Basic bioinformatics tools will be used to analyse the sequential and 
structural data of these proteases. The results obtained will be correlated with 
the data obtained from the literature search to arrive at a consensus for the 
recommendation in the design of a structural motif for a possible prodrug 
carrier. This study includes the following steps, 
• Extraction of the protein sequences for the proteases under study from 
the GenBank repository. 
• Alignment search to find similar sequences using BLASTp. 
• Research published literature for related information on the selected 
proteases having sequence similarity. 
• Multiple sequence alignment between the various proteases using 
ClustalW. 
• Search and identification of important motifs present in the primary 
protease under study. 
• Homology modelling of the structure for the proteases under study using 
Swiss Model server. 
• Structure Alignment and Analysis. 
• An organised report on the knowledge obtained from this study towards 
creating a structural motif for the purpose of creating prodrug carriers 
using the studied proteases. 
 
2. MATERIALS AND METHODS 
2.1 Bacterial Strains and Proteases. 
The strains and proteases of the primary bacteria studied in this work are 
described in Table 1. It also includes the other bacterial strains and proteases 
used by various studies used as the source of primary literature in this study.  
PROTEASE (Accession 
No) 
SOURCE 
ORGANISM 
          REFERENCE 
 
PgtE (AAF85951.1) 
 
Pla (NP_995574.1) 
 
OmpT(NP_287408.1) 
 
 
PrtA (NP_928000.1) 
 
RgpA(YP_001930085.1) 
 
 
RgpB(YP_001929582.1) 
 
Kgp(YP_001929844.1) 
 
 
Salmonella enterica 
serovar 
Typhimurium 
 
Yersinia pestis 
 
 
Escherichia coli 
 
 
Photorhabdus 
luminescens subsp. 
Laumondii TT01 
 
 
Porphyromonas 
gingivalis ATCC 
33277 
 
 
Porphyromonas 
gingivalis ATCC 
33277 
 
 
Porphyromonas 
gingivalis ATCC 
33277 
 
 
Guina et al., 2000 
 
 
 
Revazishvilli et al., 2008 
 
 
 
Skyberg et al., 2006 
 
 
Duchaud et al., 2003 
 
 
Naito et al., 2008 
 
Naito et al., 2008 
 
Naito et al., 2008 
 
 
 2.2 Sequence Alignment. 
This process involves the method of arranging DNA, Protein or RNA 
sequences to find similar regions among the sequences, which may indicate 
evolutionary, structural or functional relationships among them (Mount, 2004). 
Sequence alignment techniques are widely used in all forms of genomics and 
proteomics studies. For example a similar study based on finding structural 
and functional relationships among bacterial protease precursors used an 
extensive amount of sequence alignment techniques for analysing the 
different bacterial protein strains under study (Serkina et al., 2001). 
 
2.2.1 BLAST 
BLAST identifies the local regions of similarity between different sequences, it 
can be used to compare protein or nucleotide sequences to the sequences 
already present in databases to identify similarities and provide a statistical 
idea about the evolutionary and functional relationships between them 
(Altschul et al., 1990). The protein sequence of the primary bacterial protease 
under study, the surface protease PgtE of Salmonella enterica serovars was 
obtained from the Genbank database (accession no. AAF85951.1). It is an 
outer membrane protease, 312 amino acids long and is taken from the 
Salmonella enterica subspecies, Salmonella enterica serovars Typhimurium 
(Guina et al., 2000). A local alignment search was used on the obtained 
sequence using BLASTp to compare it with sequences in the GenBank 
repository. Both these services were accessed through the NCBI website 
(http://www.ncbi.nlm.nih.gov/). The BLAST results were analyzed and the 
highly similar sequences were isolated so as to study the published literature 
to find if they possess any functional similarity and structural similarity to the 
protease PgtE of Salmonella enterica serovars.  
 
The protein sequence of the second protease under study the alkaline 
metalloprotease PrtA of Photorhabdus luminescens was obtained from the 
GenBank database (accession no. CAE12950.1). Its an alkaline 
metalloprotease similar to serralysins, 480 amino acids long and has been 
isolated from the bacteria Photorhabdus luminescens subspecies laumondii, 
strain TTO1 (Duchaud et al., 2003). A BLASTp search was run using the 
NCBI server (http://www.ncbi.nlm.nih.gov/) and the similar sequences were 
analysed to find functional and structural correlation to the protease under 
study using published literature.  
 
The same procedure was repeated with the gingipains, RgpA, RgpB and Kgp, 
the protein sequences for which were obtained from the Genbank repository. 
The arginine specific cysteine proteases, RgpA (accession no. 
YP_001930085.1) and RgpB (accession no. YP_001929582.1) were isolated 
from the bacteria Porphyromonas gingivalis strain ATCC 33277, and were 
1703 and 736 amino acids long respectively. The lysine specific cysteine 
protease Kgp (accession no. YP_001929844.1) was also obtained from the 
same strain of the bacteria and was 1723 amino acids long (Naito et al., 
2008). BLASTp was again used to study the similar sequences of these 
gingipains and identify any sequences that might have functional similarity 
using an extensive search of published literature.  
The NCBI server (http://www.ncbi.nlm.nih.gov/) was mainly used throughout 
the BLAST analysis process. 
 
2.2.2 CLUSTALW 
Multiple sequence alignment is used to align two or more sequences (Wang 
and Jiang, 1994). It can be used to find conserved regions among the 
sequences of study and this can be used to identify similar structural motifs 
among different sequences thereby providing information to isolate active 
sites and other important regions. Multiple sequence alignment can be further 
used to create phylogenetic trees and gauge the evolutionary distances 
between various sequences; this proves very helpful to study the evolutionary 
relationships between related sequences (Chenna et al., 2003). ClustalW is 
one such multiple sequence alignment tool, which is used to align DNA or 
protein sequences and is very useful in identifying similarities, differences and 
identities among diverse sequences (Thompson et al., 1994). Phylograms and 
cladograms can also be generated to study the evolutionary relationships 
between sequences. ClustalW can be accessed using the European 
Bioinformatics Institute web server (http://www.ebi.ac.uk/Tools/clustalw2). It’s 
a widely used tool and is used in a variety of bacterial protease study as well 
like the study on the effects of overproduction or absence of periplasmic 
protease DegP in bacterial growth (Onder et al., 2008). 
 
The PgtE protein sequence obtained was aligned with two other omptins 
known to have sequence similarity, the surface protein Pla of Yersinia pestis, 
which is a major virulence factor of plague and outer membrane protease 
OmpT of E. coli using ClustalW2. The Pla protein sequence was obtained 
from the Genbank database (accession no. ABX84823.1), isolated from 
Yersinia pestis Angola strain and measuring 312 amino acids long (Eppinger 
et al., 2010). The OmpT sequence was obtained from the Genbank repository 
(accession no. ABA54754.1), isolated from Escherichia coli and measuring 
317 amino acids long (Skyberg et al., 2006). The results obtained were 
analyzed to identify conserved regions among the protein sequences and 
significant differences as well.  
 
To analyze the substrate specificity of surface protease PrtA of Photorhabdus 
luminescens, the 6 known proteins of the actual 16 it was observed to cleave, 
were subjected to multiple sequence alignment, so as to identify any similarity 
in the sequential pattern of the substrates. This would help to hypothesize a 
suitable structural motif on the substrate for PrtA cleavage. ClustalW2 web 
tool was used to create the multiple sequence alignment through the EBI web 
server (http://www.ebi.ac.uk/Tools/clustalw2). The results obtained were 
analyzed to find any conserved regions among the sequences. The 
Phylograms and cladograms constructed were also accessed to ascertain the 
evolutionary significance.  
 
2.3 Motif Identification 
A sequence motif is the highly conserved region in an amino acid or nucleic 
acid sequence that is widespread and can be hypothesized to have some 
biological significance (Stormo, 2000). Motif finders are tools that identify such 
motifs in a given sequence; they can be very useful in finding about the 
function of a given sequence. MOTIF Search is one such tool which analyses 
the sequences that should be submitted in FASTA format, compares it with 
databases such as PROSITE and identifies the widely conserved motifs. Motif 
finders are used nowadays in a variety of studies such as genome wide 
identification of binding sites in various sequences (Kang et al., 2009). 
 
2.4 Homology Modelling  
Homology modelling is the process of modelling a structure for protein 
sequence, which doesn’t have a recognized structure by comparing the 
sequence to other homologous proteins having known structures (Ginalski, 
2006). It’s a comparative modelling technique, which normally involves three 
steps, one, finding homologues in the Protein Data Bank (PDB), two, aligning 
the primary sequence with the retrieved protein sequences using multiple or 
single sequence alignments and three, calculating the structure and refining it 
(Zhang and Skolnick, 2005). Homology modelling techniques are very useful 
in finding conserved regions between sequences, in drug design studies and 
protein interaction studies. Homology modelling is based on the idea that 
structures of proteins that are slightly related have more observable 
conserved regions than the respective protein sequences (Renom et al., 
2000).  Homology modelling can be performed using various computational 
tools such as MODELLER, GeneSilico, and HHPred etc. Swiss-Model is a 
very useful reliable web server that can be used to create basic homology 
models. Homology modelling is widely used in bacterial protease studies, for 
example in a extensive study on the Pla protease of Yersinia pestis Swiss 
Model server has been used to create models (Suomalainen et al., 2007). 
 Of the three omptins under study, only OmpT of E. coli has an accepted 
structure at the PDB database (accession no. 1I78), PgtE of Salmonella and 
Pla of Y. pestis don’t have any recognized protein structure annotated in the 
PDB repository. To study the conserved regions between PgtE and Pla of Y. 
pestis and OmpT of E. coli, the homology modelling technique was utilized to 
model tertiary protein structures for both PgtE and Pla using the OmpT 
structure as a template. The Swiss Model web server 
(http://swissmodel.expasy.org/), was used to model the crystal structures for 
the protein sequences of PgtE and Pla. The sequences in the FASTA format 
were submitted in the query space and the template structure required was 
selected from the PDB repository using the accession number mentioned for 
the crystal structure of OmpT. Structure validation and evaluation for the 
modelled structures were carried out using different techniques such as 
Ramachandran Plot and tools like ProCheck, Verify3D. A hypothesis on the 
possible functions of the proteinase PgtE that can be accessed from its 
structure was done using the ProFunc tool available in the EBI server 
(http://www.ebi.ac.uk/thornton-srv/databases/profunc/) and a complete set of 
PDBsum analysis on the modelled structure was also done using the same 
server (http://www.ebi.ac.uk/pdbsum/).  
 
 
 
 
 
3. RESULTS AND DISCUSSION 
 
3.1 PgtE 
3.1.1 Sequence Alignment 
The proteins sequence of PgtE obtained from the GenBank repository was 
run in an alignment search using BLAST. The sequences similar to that of 
PgtE and of those that were considered to be important to the study, because 
of the functional similarity they shared with PgtE, like ECM components 
cleavage, are listed in Table: 2. The list of proteases that contained sequence 
similarity to PgtE obtained through BLASTp has been listed in Appendix 1; the 
four proteases from Table 2 were selected for this study because they had 
been identified to have a certain level of functional similarity to PgtE through 
the research on published literature. In the four we know that the Pla of 
Yersinia pestis and OmpT of E. coli were from the same family of outer 
membrane proteases, the omptins. The other two proteases were further 
analysed among published literature to find correlation in their to that of PgtE. 
Through which we could determine a common structural motif for PgtE action 
on its substrates.  
 
 
 
 
 
 
 
TABLE: 2 
 
Accession 
Number 
Name of The 
Protein 
Source Organism Sequence 
Similarity 
Score 
 
NP_995574.1 
 
YP_001176628.1 
 
 
NP_287408.1 
 
NP_857613.1 
 
Outer membrane 
protease (Pla) 
 
 
 
Outer membrane 
protease (OMP1) 
 
Outer membrane 
protease (OmpT) 
Outer membrane 
protease (OMP2) 
 
Yersinia pestis 
biovar Microtus 
strain. 91001 
 
Enterobactor clocae 
subsp. clocae 
ATCCC 13047 
 
 
 
Escherichia coli 
 
 
 
Erwinia sp. Ejp 556 
 
484 
 
 
 
490 
 
 
 
 
 
299 
 
 
 
461 
 
Fig 1: Shows the phylogenetic tree drawn for the four proteases obtained from 
the BLAST results along with PgtE. The evolutionary distance between them 
is also shown. 
 From the phylogenetic tree that was generated through the ClustalW analysis, 
the evolutionary divergence and distance between the different proteases 
used in that experiment could be observed. This phylogram shows that, PgtE, 
Pla and OmpT have a common ancestor, which is understandable because 
they belong to the same category of proteases called the omptins. It can be 
also seen from the evolutionary distance calculated that PgtE and Pla had 
diverged recently though OmpT is considerably a far distance off. The other 
proteases OMP1 and OMP2, though they have sequence similarity to PgtE, 
they are far distanced in evolutionary relation. It’s understandable because 
they are both from different protease families entirely. The significance of this 
result is that it has been known that while evolving PgtE and the omptins had 
developed different modifications to their surface loops, which differentiates 
their functions. The omptin family presents a highly interesting group of 
evolutionarily related proteases that have evolved to fit into the life style of 
their host bacteria and prove how the β-barrel through the evolutionary 
process can be modified functionally by small changes at critical exposed 
sites on the surface (Kukkonen and Korhonen, 2004). 
 
 
ClustalW Results 
The next step on the analysis of PgtE involved the multiple sequence 
alignment of PgtE with all the proteases from Table 2 using ClustalW. 
 
 Fig 2: Shows the ClustalW alignment of five proteases- PgtE of Salmonella, 
Pla of Y. pestis, OmpT of E.coli and the outer membrane proteases of both E. 
clocae and Erwinia sp. ‘*’ represent the conserved regions among the 
sequences. 
 
 
From analysing the above alignment and the alignment scores obtained 
through the ClustalW tool, it is clear that all these sequences possess 
considerable sequence similarity as well as the presence of conserved 
regions could be clearly identified, especially at the C- terminal and 
throughout the sequences except after the start from the N-terminal. There 
are a few gaps, which maybe the results of mutations during evolution.  
 
3.1.2 Motif Identification 
MOTIF Search tool was used to find the already recognised motifs among the 
PgtE protein sequence by comparing with the PROSITE database. Three 
known motifs were found in PgtE, two Aspartyl protease omptin family 
signatures and an EF- hand Calcium binding domain. They are illustrated in 
Table: 3 below. 
  FOUND MOTIF POSITION  PROSITE ID            DESCRIPTION 
 
WTDRSIHPDT 
 
 
 
 
115-124 
 
 
 
OMPTIN_1 
(PSOO834) 
 
 
 
Aspartyl protease, 
omptin family 
signature 1. 
 
AGYQETRFSWTAR
GGSY 
 
 
152-168 
 
 
 
OMPTIN_2 
(PS00835) 
 
 
Aspartyl protease, 
omptin family 
signature 2. 
 
DTDTGRKLSQLDW 
 
53-65 
 
EF_HAND_1 
(PS00018) 
 
EF-hand calcium 
binding domain. 
  
3.1.3 Homology Modelling 
To study the conserved domains using the structural data of the protein 
sequences, the crystal structure of PgtE was modelled using Swiss-Model 
homology modelling tool, using OmpT of E.coli as a valid template, since they 
share more that 48% sequence similarity. The structure of Pla of Y. pestis 
was also modelled using the same process. Both these modelled structures 
were super imposed on each other and were allowed to undergo structure 
alignment to study the differences in their loops, which corresponds to their 
specific activities. 
The modelled structures of PgtE and Pla shows a high range of similarity, 
they both possess the characteristic cylindrical barrel shape of the omptins, 
much like OmpT of E. coli.  In both the structures there are 5 (L1 - L5) 
exposed loops on the surface and ten transmembrane beta strands, this can 
be seen normally within all of the omptins as well (Rutten et al., 
2001;Kukkonen et al., 2001). The transmembrane beta strands can undergo 
large substitutions in their exposed areas of the surface, since they are very 
stable (Wimley, 2003). 
 
 
Fig 3: Jmol image showing the cylindrical structure of the modelled PgtE of 
Salmonella enterica serovar Typhimurium. 
 
 Fig 4: Jmol image showing the cylindrical structure of the modelled Pla of Y. 
pestis. 
 
 
 
 
 
 
 
 Fig 5: A model showing the different loops and important surface residues in 
superimposed structure of PgtE and Pla. (Adapted from Ramu et al., 2007) 
 
 
 
 
 
 
 
 
 
The modelled structures of PgtE and Pla shows a high range of similarity, 
they both possess the characteristic cylindrical barrel shape of the omptins, 
much like OmpT of E. coli.  In both the structures there are 5 (L1 - L5) 
exposed loops on the surface and ten transmembrane beta strands, this can 
be seen normally within all of the omptins as well (Rutten et al., 
2001;Kukkonen et al., 2001). The transmembrane beta strands can undergo 
large substitutions in their exposed areas of the surface, since they are very 
stable (Wimley, 2003). These substitutions could be used as a way of 
converting or adding properties to the omptins, which they didn’t have in the 
wild condition. For example, studies have shown that experiments have 
successfully converted Pla into a PgtE like sequence, by performing simple 
substitutions, which further allowed Pla to have PgtE like functions, such as 
activating proMMP-9 (Ramu et al., 2007). These substitution regions and 
loops are shown clearly in Figure 5. 
Further the binding sites of PgtE were analysed through PDBsum in the EBI 
web server, the position of the binding sites and the residues in it were 
identified. 
Residue type colouring scheme is given below, 
Red – Negative Residues (D, E). 
Blue – Positive Residues (H, K, R). 
Purple – Aromatic Residues (F, Y, W). 
Yellow – Cysteine (C). 
These are the binding sites that are normally involved in the catalytic activity 
of PgtE. 
 
  
Fig 6: Shows the different general binding sites observer in PgtE in colour 
generated by PDBsum, each colour corresponds to the different residues 
involved. 
 
 
 
 
 
 
3.2 PrtA 
The protein sequences of the substrates in which PrtA was known to act was 
analysed through a refined study of published literature. It was observed to be 
active against 16 proteins in Manduca sexta of which 6 where known to have 
some kind of immunological activity. The other 10 were unknown proteins with 
no clarity on their function. These proteins also known as PAT proteins are 
listed in Table 4 below. 
 
  PAT PROTEIN  NAME & ACCESSION NO.  HYPOTHESIZED 
FUNCTION 
 
     PAT - 35a 
     PAT - 35b 
     PAT - 41a 
     PAT - 52 
     PAT - 54a 
     PAT - 63 
 
Scolexin A (AAD14591.1) 
Scolexin B (AAD14592.1) 
SPH-3 (P13082.1) 
Serpin-1 (AAC47343.1) 
HAIP (ACW82749.1) 
 β1,3-GRP-2 (AAN10151.1) 
 
           Immunological 
           Immunological 
           Immunological 
           Immunological 
           Immunological 
           Immunological 
 
All the six PAT proteins were analysed using multiple sequence alignment to 
identify conserved regions that might indicate some kind of substrate 
specificity by PrtA, ClustalW from the EBI server was used for this process. 
 
 
 
 
ClustalW Result 
 
The multiple sequence alignment of the PAT proteins showed that they don’t 
share any considerable sequence similarity, though all of them shared some 
immune related function. A phylogenetic tree was built was also built which 
showed the considerable evolutionary distance between the different PAT 
proteins and how they have diverged. 
 
 
 Fig 7: Shows the ClustalW alignment between the six PAT proteins on which 
PrtA acts.’*’ Represents the conserved regions among the sequences. 
 
 
 Fig 8: Phylogenetic Tree showing the evolutionary divergence and distance 
between the six PAT proteins on which PrtA acts. 
 
From the phylogram it can be observed that Scolexin A and B have a 
common ancestor which is irrefutable because they are just variants of the 
same protease. Also an interesting thing was that HAIP and Serpin- 1 share 
common ancestry with recent divergence, though there is not much sequence 
similarity. SPH-3 also shares a common ancestor with them, though it has 
diverged earlier. 
 
3.3 GINGIPAINS 
The protein sequences of the gingipains RgpA and Kgp of P. gingivalis was 
obtained from the Genbank repository through the NCBI web server. They 
were subjected to multiple sequence alignment using ClustaW through the 
EBI web server.  
 
  
 
 Fig 9: Shows the ClustalW sequence alignment of Rgp and Kgp from the 
bacteria P. gingivalis. 
 
 
Both these sequences are conserved for the major part of the sequence right  
from residue numbers 858-882 to the end of the C- terminal with a limited 
number of deviations in between, though the differences in the sequences at 
the N-terminal region can be hypothesized as the reason for their specificity to 
cleave after an arginine and lysine residue respectively. Further more there 
are a lot of gaps in the alignment showing the mutations that might have 
occurred. 
Since the gingipains activate proMMPs such as proMMP-9, similar to PgtE of 
Salmonella, a sequence alignment between the gingipains and PgtE was 
carried out using ClustalW to find if there were any conserved regions. 
 Fig 10: Shows the sequence alignment between Kgp of P. gingivalis and PgtE 
of Salmonella (only part of the Kgp sequence corresponding to PgtE is shown, 
the complete Kgp sequence is listed in Appendix 2). 
 Fig 11: Showing the sequence alignment between RgpA of P. gingivalis and 
PgtE of Salmonella (only part of RgpA sequence that is aligned to the PgtE is 
shown, the complete RgpB sequence is listed in Appendix 3). 
  
 
Fig 12: Showing the sequence alignment between RgpB of P. gingivalis and 
PgtE of Salmonella (only the part of RgpB sequence that aligns with PgtE is 
shown, the complete RgpB sequence is listed in Appendix 4) 
 All three gingipains share a few conserved domains with PgtE of Salmonella, 
with the lysine specific cysteine protease Kgp getting the highest alignment 
score, RgpB and RgpA lying after that respectively. Also a lot of gaps can be 
identified in all three alignments, which might have been mutations during the 
evolutionary process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. DISCUSSION 
 
Bacterial proteases are widely spread among all types of bacteria present; 
they take part in important functions like evasion and colonization of the host’s 
immune system, intake of nutrients for proliferation and growth, aiding in 
dissemination and causing damage to the tissue at the time of infection 
(Miyoshi and Shinoda, 1997). They also play other subtle functions, which 
have been recently identified during the interaction between bacteria and the 
host organism, from the cleavage of receptors on the cell surface, protease 
inhibitor inactivation, stopping cytokine networks and disruption of cascade 
activation pathways (Travis and Potempa, 2000). Our study primarily focused 
on finding bacterial proteases that could prove to be helpful for that particular 
process, site directed drug delivery. The study was based on a few recent 
interesting research results, which identified bacterial proteases with activity 
that could be utilized in the way proposed. Of the bacterial proteases of 
interest, three particular proteases were chosen as the primary targets of 
study, PgtE of Salmonella enterica serovar Typhimurium, PrtA of 
Photorhabdus luminescens and the Gingipains of Porphyromonas gingivalis. 
These proteases where chosen particularly because of their specific activity 
on some host components such as the extracellular matrix (ECM) and other 
proteases in the host system as well. PgtE for example was studied to have 
activity on the ECM and more importantly it was able to activate proMMP-9 as 
well as mimic the activities of MMPs (Ramu et al., 2007). PrtA act on a class 
of proteins, which have been identified to have immunological activity and the 
gingipains, RgpA, RgpB and Kgp, also degrade the ECM and activate 
proMMPs. 
 
Multiple sequence alignment of PgtE using ClustalW, with four different 
proteases (Pla of Y. pestis, OmpT of E. coli, OMP of E. clocae and OMP of 
Erwinia sp.) obtained through BLAST search, yielded results that showed a 
high range of conserved regions among the proteases. Of which Pla and 
OmpT had higher sequence similarity, which was understandable because 
they belong to the same family of omptins, which was further proven by 
phylogenetic analysis. All the proteases that were used to compare with PgtE 
were observed to have activity on the ECM components. Pla was observed to 
be good plasminogen activator, which is similar to the function of PgtE 
activating plasminogen, though the extent of plasminogen activation by Pla 
was much higher. It should be noted that Pla induces ECM degradation via 
the activation of plasminogen into plasmin (Lähteenmäki et al., 2005). Also 
the reduced effect of PgtE on plasminogen when compared to Pla, is due to 
structural adaptations and actually helps Salmonella in recognizing the host 
macrophage cell produced proMMP-9 (Ramu et al., 2007). OmpT has 
relatively less in plasminogen activation compared to Pla and PgtE. The ability 
of PgtE to activate proMMP-9 and the inability of Pla, which is similar to it, is 
due to those structural adaptations and sequential differences. It has been 
found that by small substitutions in Pla, specifically 2 amino acid substitutions 
in L5 and 27 amino acids in L1 and L3, it could be made to act as PgtE in the 
activation of proMMP-9.  It has been observed that the loops, L1, L3 and L5 
have an important role in the proMMP-9 activation by PgtE (Ramu et al., 
2007). Structural alignment and analysis also showed the differences in the 
structure and sequence of Pla and PgtE, which could be purported as the 
reason for different substrate specifity. The other important activity, which has 
been unique to it among these proteases studied, is the mimicking of MMPs. 
PgtE is able mimic the activity of MMP-9 and act as a gelatinase in addition to 
activating the MMP-9 precursor. Its ability to cleave gelatin has been 
identified, the loops L1 and L5 playing an important role in it. Another 
important thing to be noted is that there is a distinct similarity in the loops 
present in the hemopexin domain of PgtE and MMP-3 (stromelysin-1). It has 
been already proved that MMP-3 activates proMMP-9, cleaves gelatin and 
also inactivates the protease inhibitor α2-antiplasmin (Lijnen et al., 2001). 
FPHGVRGI of L3 and IIDKTSGDTAYF of L5 in PgtE align to the amino acid 
sequences FPPTVRKI and ISDKEKNKTYFF of MMP-3.  
 
When designing a possible structural motif for a peptide substrate from the 
cleavage data of PgtE, which could be used as a prodrug carrier, the above 
said recommendations can be taken into account. It could be suggested that if 
the peptide substrate on which the prodrug is planned to be attached should 
have some general specifications so that it would be cleaved by PgtE. The 
known substrate specifity of PgtE, as well as, substrate specificities of 
proteases having similar function like PgtE can be used for that purpose. For 
example, PgtE has a calcium binding EF- hand domain, which proves that it 
might bind to the calcium ions if found in its substrates. This can be further 
proved by the fact that, proMMP-9 which is a substrate for PgtE does have 
calcium ions in it (Kimata et al., 2006).  Similarly the preference of PgtE in its 
substrate for specific prime site residues can also be taken as an example for 
this. 
 
PrtA of Photorhabdus luminescens is a serralysin that helps in the virulence of 
the bacteria and is involved in the early infection stages of the host organism 
(Marokhazi et al., 2004). PrtA action on a family of proteins called PAT 
proteins was analysed, in the entire set of PAT proteins that PrtA cleaves six 
are known to have immunological functions. ClustalW analysis was carried 
out between the known PAT proteins to understand any similarity in the 
sequences. Though they have similar functions the conserved regions among 
the proteins were very minimal, which does not elucidate any substrate 
specificity on the part of PrtA. Phylogenetic analysis was also done to study 
the evolutionary divergence among the PAT proteins. The specifity of the 
cleavage site of PrtA was studied in hydrolysis of insulin A, B and β-lipotropin. 
PrtA was observed to show preference to hydrophobic amino acids in specific 
positions unlike other serralysins, also another important result observed was 
PrtA could even cleave peptides as short as six amino acids (Marokhazi et al., 
2007). Further it was evident that PrtA required interaction with substrates on 
the either side of the scissile bond for efficient cleavage during peptide 
hydrolysis. In biological peptides, PrtA has higher preference for aliphatic 
residues and a preference in choosing valine over leucine at the substrate 
position P2’ which is similar to other serralysins (Louis et al., 1999). These 
properties and specifications of PrtA should be taken into account when 
considering developing peptide substrates of PrtA as prodrug carriers. 
 
The gingipains were taken into the study as they were comparable to PgtE in 
their function, both Rgp and Kgp activated proMMPs. ClustalW was used to 
align Rgp and Kgp to study the conserved regions, as well as the gingipains 
were aligned with PgtE individually to identify any conserved regions. The 
results showed that Kgp was more conserved towards PgtE than Rgp; though 
they are entirely different proteases the conserved regions found among their 
sequences could be the reason for their related function. Previous studies 
have shown the specifity of gingipains in cleaving the substrates having 
particular prime site residues (Ally et al., 2003). Identification of specificity in 
P2′ and P3′ regions observed during the cleavage of gingipains in it 
substrates, helps to define the properties of their cleavage sites and predict 
the modelling of a suitable structural motif. 
 
So by studying the known and other possible substrates of these proteases 
one could suggest, substrate specificities, cleavage site specifics and 
important residues in the substrate that are required for cleavage, to define a 
structural motif that can be used to model novel prodrug carriers. 
 
 
 
 
 
 
 
 
5. CONCLUSION 
 
The importance of bacterial proteases on virulence of bacteria gave rise to a 
wide study of potential protease inhibitors other than the natural ones present 
in the immune system. Although the study on harnessing these proteases as 
tools for drug delivery has not been that widely researched, it promises to be 
a new and exciting way of combating bacterial diseases. The main goal of this 
study was to identify and understand a number of bacterial proteases that 
have specific functions such as degradation of ECM and activation of 
proMMPs to assess them for the possible use in drug delivery purposes. The 
primary proteases of study, PgtE of Salmonella enterica and PrtA of 
Photorhabdus luminescens were analysed using their sequence data, along 
with extensive study on published literature. Their structural and sequential 
importance towards the substrate specificity has been addressed; in addition, 
other related proteases having similar functions were also elaborated on. This 
project work forms the beginning of an extensive project which would likely 
involve the creation of peptide libraries and large scale cleavage studies of 
selected proteases and synthetic protein carriers, with use of recombinant 
enzymes, to help to create a novel prodrug carrier that can be activated in the 
microenvironments of cancer or infected human tissues. This study has 
identified the substrate specificities and cleavage site analysis of a selection 
of such proteases, which form the foundation for further research. 
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2. Complete Protein Sequence Of Kgp 
 
3. Complete Sequence of RgpA 
 
 
 
4. Complete sequence of RgpB 
 
 
 
 	  
